OVERVIEW

Why Gene Therapy for Hemophilia? Exploring the Challenges of Current Therapies is organized by National Hemophilia Foundation (NHF).

CME / ABIM MOC Released: 8/23/2018
Reviewed and Renewed: 9/6/2019
Available for Credit Until: Sunday, September 6, 2020

Description:
This webinar is a discussion about the current clinical challenges associated with the use of factor replacement therapy in hemophilia patients and the part gene therapy may play in the future. Upon completion of this activity, participants will have increased knowledge regarding the potential role of gene therapy to address challenges in current hemophilia treatment.
This activity is part of the “Clinical Advances in Gene Therapy for Hemophilia” educational series which is presented through a collaboration between Medscape, NHF, the European Haemophilia Consortium and the World Federation of Hemophilia. The program is supported by an independent educational grant from BioMarin.

Additional details will be posted as soon as information is available.